Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies

Overall survival (OS) has improved with increasing use of novel agents in multiple myeloma (MM). However, the disease course remains highly variable, and the heterogeneity largely reflects different genetic abnormalities. We studied the impact of the Mayo risk-stratification model of MM on patient o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kapoor, Prashant, Fonseca, Rafael, Rajkumar, S. Vincent, Sinha, Shirshendu, Gertz, Morie A., Stewart, A. Keith, Bergsagel, P. Leif, Lacy, Martha Q., Dingli, David D., Ketterling, Rhett P., Buadi, Francis, Kyle, Robert A., Witzig, Thomas E., Greipp, Philip R., Dispenzieri, Angela, Kumar, Shaji
Formato: Artigo
Idioma:Inglês
Publicado em: Mayo Foundation for Medical Education and Research 2010
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2878257/
https://ncbi.nlm.nih.gov/pubmed/20511484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4065/mcp.2009.0677
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados